Success Metrics

Active Trials
2(29%)

Phase Distribution

Ph not_applicable
6
86%
Ph phase_2
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Other(3)

Detailed Status

unknown3
Recruiting2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (14.3%)
N/A6 (85.7%)

Trials by Status

recruiting229%
unknown343%
not_yet_recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7